Zimmer Biomet Director Robert Hagemann Acquires Phantom Stock Units

Insider Filing Overview

Director Robert Hagemann acquired 306.066 Phantom Stock Units in Zimmer Biomet Holdings, Inc. (ZBH) on September 30, 2026.

Transaction Details

• Security: Phantom Stock Units (convertible 1-for-1 to cash value of common stock)
• Transaction Code: A (Grant, award, or other acquisition)
• Units Acquired: 306.066
• Conversion / Exercise Price: $89.85
• Reported Price Per Share: $0.00
• Implied Value: ~$27,500.03
• Post-Transaction Holdings: 33,660.840 Phantom Stock Units

Context and Footnote Details

• The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
• The units are scheduled to be settled in cash in five annual installments starting within 60 days following the end of the calendar year in which the reporting person ceases service as a Director.
• Total holdings also include 85.331 phantom stock units accrued via dividend reinvestment on July 31, 2026.

Market Significance

This transaction reflects routine, scheduled non-employee director compensation deferrals rather than an open-market discretionary purchase or sale. Consequently, the trading significance is categorized as Low.